Search Result "systemic lupus erythematosous"
Implication of CD154/CD40 Interaction in Healthy and Autoimmune Responses
Journal: Current Immunology Reviews
Volume: 5 Issue: 4 Year: 2009 Page: 285-299
Author(s): Ghada S. Hassan, Manjit Rana, Claire Leveille, Amal Nadiri, Malek Jundi, Maria Polyak, Youssef El-Fakhry, Walid M. Mourad
Use of Glucocorticoids in Pregnancy
Journal: Current Pharmaceutical Design
Volume: 16 Issue: 3 Year: 2010 Page: 3616-3637
Author(s): L. Lunghi, B. Pavan, C. Biondi, R. Paolillo, A. Valerio, F. Vesce, A. Patella
Safety of Systemic Biologic Agents in the Treatment of Non-malignant Skin Disorders
Journal: Current Drug Safety
Volume: 12 Issue: 2 Year: 2017 Page: 76-94
Author(s): George Badavanis,Efstathia Pasmatzi,Alexandra Monastirli,Dionysios Tsambaos
Anti-TNFs for Postoperative Recurrence in Crohns Disease: The Ifs and Hows
Journal: Current Drug Targets
Volume: 11 Issue: 2 Year: 2010 Page: 219-226
Author(s): D. Sorrentino, A. Paviotti, G. Fiorino
What Animal Models are Best to Test Novel Rheumatoid Arthritis Therapies?
Journal: Current Rheumatology Reviews
Volume: 4 Issue: 4 Year: 2008 Page: 277-287
Author(s): Paul H. Wooley
Leukocyte Traffic Blockade as a Therapeutic Strategy in Inflammatory Bowel Disease
Journal: Current Drug Targets
Volume: 14 Issue: 1 Year: 2013 Page: 1490-1500
Author(s):
Anti-TNF Antibodies in Inflammatory Bowel Disease: Do We Finally Know How it Works?
Journal: Current Drug Targets
Volume: 14 Issue: 1 Year: 2013 Page: 1421-1432
Author(s): Angelos Oikonomopoulos, Welmoed K. van Deen, Daniel W. Hommes
On Therapeutic Drug Monitoring of Thiopurines in Inflammatory Bowel Disease; Pharmacology, Pharmacogenomics, Drug Intolerance and Clinical Relevance
Journal: Current Drug Metabolism
Volume: 10 Issue: 9 Year: 2009 Page: 981-997
Author(s): Dirk P. Van Asseldonk, Nanne K.H. de Boer, Godefridus J. Peters, Agnes I. Veldkamp, Chris J. Mulder, Ad A. Van Bodegraven